PLOS ONE 2016 Apr 27;11(4):e0153163

The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study

Impact Factor 4.4

NATURE COMMUNICATIONS 2015 Jun 12;6:7208

Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels

Impact Factor 11.3

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 2015 Apr;44(2):578-86

Adiposity as a Cause of Cardiovascular Disease: A Mendelian Randomization Study in up to 50,117 Individuals

Impact Factor 7.5

DIABETES 2015 Volume 64 Issue 5: 1841-1852

Age- and Sex-specific causal Effects of Adiposity on cardiovascular Risk Factors

Impact Factor 8.5

ANTICANCER RESEARCH 2006 26: 1719-1726

Changes in the Circulating Plasma Levels of VEGF and VEGF-D after Adjuvant Chemotherapy in Patients with Breast Cancer and 1 to 3 Positive Lymph Nodes

Impact Factor 1.5

INTERNATIONAL JOURNAL OF CANCER 2006 119: 2885–2894

The thymidylate synthase tandem repeat promoter polymorphism: A predictor for
tumor-related survival in neoadjuvant treated locally advanced gastric cancer

Impact Factor 4.7